secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K/A
Filed at:   2022-03-04T23:59:59+00:00
Accession:  0001213900-22-010779
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 3.03, 5.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Vaccines amends 8-K to disclose $17.2M net IPO proceeds
------------------------------------------------------------------

- Net proceeds from IPO approximately $17.2M after underwriting discount and expenses.
- IPO of 2,222,222 shares at $9.00 per share closed Feb 23, 2022.
- James Sapirstein appointed to board, replacing John Rice (resigned).
- All outstanding preferred shares converted into 5,626,365 common shares at closing.
- Representative's warrants issued for 111,111 shares at $10.35 exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390022010779/0001213900-22-010779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390022010779/ea156505-8ka1_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-010779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer